Giving Your Health a New Lift
medical-cross
Free Shipping over $199
box
  • No products in the cart.
Shop by our top categories...
    Search result for:
    Sale!

    Erlocip 150mg (Erlotinib)

    $199.00$549.00

    Active Ingredient(Generic Name): Erlotinib
    Indication: Non-small cell lung cancer, Pancreatic cancer
    Manufacturer: Cipla Limited
    Packaging: 30 tablets in 1 bottle
    Strength: 150mg
    Delivery Time: 6 To 15 days

     

     

     

     

     

    Share:

    Available Options

    ThumbnailPack SizePriceQuantity 
    30 Tablet/s $199.00
    60 Tablet/s $380.00
    90 Tablet/s $549.00
    Description
    Erlocip 150 mg Tablet is an anticancer medicine used for the treatment of non-small cell lung cancer. It is also used in a combination with gemcitabine to treat pancreatic cancer. This medicine is not recommended for use in patients less than 18 years of age.

    Major & minor side effects for Erlocip 150 mg Tablet

    • Burning or tingling sensation
    • Cough
    • Diarrhea
    • Lower back or side pain
    • Rash
    • Chills and fever
    • Blurred vision
    • Convulsions (seizures)
    • Chest pain or discomfort
    • Acid or sour stomach
    • Hair loss
    • Loss of appetite

    Uses of Erlocip 150 mg Tablet

    What is it prescribed for?

    • Non-Small Cell Lung Cancer
    • Pancreatic Cancer
    Read More
    Concerns

    Commonly asked questions

    •  

      How long does it take for this medicine to take effect?
      The amount of time required for this medicine to show its action is not clinically established.
    •  

      How long do the effects of this medicine last?
      The amount of time for which this medicine remains active in the body is not clinically established.
    •  

      Is it safe to consume alcohol while taking this medicine?
      Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
    •  

      Is this a habit forming medicine?
      No habit-forming tendencies were reported.
    •  

      Can this medicine be taken during pregnancy?
      This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
    •  

      Can this medicine be taken while breast-feeding?
      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

    When not to use?

    Allergy

    This medicine is not recommended for use in patients with a known allergy to erlotinib or any other inactive ingredients present along with this medicine.

    Warnings

    Warnings for special population

    Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

    Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
    General warnings

    Anticoagulants

    This medicine should be used with caution in patients receiving anticoagulants due to the increased risk of excessive bleeding. Close monitoring of INR, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

    Hepatic Impairment

    This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of worsening of the patient’s condition. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

    Renal Impairment

    This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

    Gastrointestinal Perforations

    This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases due to the increased risk of gastrointestinal perforations. Report any unusual symptoms to the doctor immediately. Close monitoring of clinical condition or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

    Dosage

    Missed Dose

    The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

    Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

    Interactions

    All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

    Interaction with Alcohol

    Description

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

    Instructions

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
    Interaction with Medicine
    Gastrointestinal Diseases
    This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases such as peptic ulcer disease and diverticular disease due to the increased risk of worsening of the patient’s condition. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

    Eye disorder

    This medicine should be used with extreme caution in patients suffering from eye diseases such as primary keratitis, ulcerative keratitis, conjunctivitis, etc. due to an increase in the risk of worsening of the patient’s condition. Report any unusual symptoms or worsening of eye symptoms to the doctor immediately. Close monitoring of clinical condition or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

    Renal impairment

    This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

    Hepatic impairment

    This medicine should be used with extreme caution in patients suffering from liver diseases due to the increased risk of worsening of the patient’s condition. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.
    Food interactions
    Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as nausea, vomiting, diarrhea, etc.
    Lab interactions
    Information not available.

    General Instructions

    Take this medicine as instructed by the doctor. You are advised to take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
    Pack Size

    30 Tablet/s, 60 Tablet/s, 90 Tablet/s

    Reviews

    There are no reviews yet.

    Be the first to review “Erlocip 150mg (Erlotinib)”

    Your email address will not be published.